Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00523367 · ClinicalTrials.gov registry record · NA
COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00523367 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 25 participants.
The verdict
NCT00523367, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.
Interventions
- PROCEDURE 24 hour pH testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00523367
The ClinicalTrials.gov registry entry for NCT00523367 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 24 hour pH testing is the first listed.
NCT00523367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00523367 about?
NCT00523367 is a clinical study titled "COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI". The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.
What is the current status of trial NCT00523367?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2007-08. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00523367?
The interventions under investigation include: 24 hour pH testing (PROCEDURE).
Who is sponsoring clinical trial NCT00523367?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.